HSPA4L

HSPA4L (Osp94/APG-1) is an Hsp110/SSE-subfamily molecular chaperone that prevents protein aggregation and promotes refolding of denatured substrates, supporting proteostasis under thermal, osmotic, and proteasome stress (PMID:8647834, PMID:35237814). Biochemically it acts as a holdase: it suppresses heat-induced aggregation of luciferase and, through its C-terminal SBDβ and H domains, enables disaggregation and Hsc70/Hsp40-assisted refolding, with the LH domain playing a PA28α-like role that a PA28α domain-swap can substitute for (PMID:35237814). The gene is transcriptionally driven by two distinct programs: HSF1 binding to heat shock elements in somatic cells (PMID:9006898, PMID:9144406), and TonEBP binding to a dedicated tonicity-response element (Osp94-TonE) during hypertonic stress, which additionally requires MAPK signaling and the proteasome (PMID:15018608). Genetically, HSPA4L is essential for spermatogenesis—knockout males are infertile with germ-cell apoptosis (PMID:16923965)—and acts redundantly with HSPA4 in embryonic lung maturation, where double loss causes accumulation of ubiquitinated proteins reflecting failed chaperone activity (PMID:23980576). It physically interacts selectively with Nogo-A among Hsp110 members (PMID:23909438), is post-transcriptionally repressed by miR-429 (PMID:28598115), and promotes myeloma cell survival downstream of HSF1 under proteasome stress (PMID:31899217).

1. 1996 Medium

   Established HSPA4L's identity as an Hsp110/SSE chaperone and linked it to osmotic stress, framing it as a stress-inducible proteostasis factor in the renal medulla.

   Evidence cDNA cloning and domain analysis with in vitro translation; Northern blot and in situ hybridization under hyperosmotic and heat stress in mIMCD3 cells and kidney

   PMID:8647834

   Open questions at the time

   • Chaperone activity inferred from domain architecture, not demonstrated
   • No substrate identified at this stage
2. 1997 High

   Revealed cell-type-specific transcriptional control, showing HSF1 drives heat-inducible expression in somatic cells while germ cells express HSPA4L constitutively and non-inducibly.

   Evidence Nuclear run-on, EMSA, in situ hybridization, and W/Wv mutant testis analysis

   PMID:9006898 PMID:9144406

   Open questions at the time

   • Functional role in germ cells not yet tested by loss-of-function
   • Mechanism of germ-cell-specific non-inducibility unresolved
3. 2004 High

   Defined a second, tonicity-specific promoter element and its trans-acting factor, distinguishing osmotic from heat-shock induction of HSPA4L.

   Evidence Luciferase reporters, EMSA showing TonEBP binding to Osp94-TonE, and pharmacological inhibition of MAPK/proteasome in mIMCD3 cells

   PMID:15018608

   Open questions at the time

   • Mechanism linking proteasome activity to transcriptional induction unclear
   • In vivo relevance of TonE element not tested
4. 2006 High

   Provided the first in vivo loss-of-function evidence that HSPA4L is required for spermatogenesis and protects against osmotic stress.

   Evidence Hspa4l knockout mouse with histology, TUNEL, sperm count/motility, and immunohistochemistry

   PMID:16923965

   Open questions at the time

   • Molecular chaperone substrates in germ cells not identified
   • Partial (~42%) infertility implies compensation that was uncharacterized
5. 2013 Medium

   Identified a selective physical partner, distinguishing HSPA4L from other Hsp110 members and linking it to neuronal stress responses.

   Evidence Affinity precipitation, reciprocal co-immunoprecipitation, and proximity ligation assay in primary hippocampal neurons

   PMID:23909438

   Open questions at the time

   • Functional consequence of the Nogo-A interaction not established
   • Whether HSPA4L chaperones Nogo-A unknown
6. 2014 High

   Demonstrated genetic redundancy with HSPA4 and directly tied HSPA4L to clearance of ubiquitinated proteins in a developmental context.

   Evidence Hspa4l/Hspa4 double-knockout mice with histology, proliferation/apoptosis assays, and Western blot for ubiquitinated proteins and surfactant markers

   PMID:23980576

   Open questions at the time

   • Specific substrates accumulating in lung not identified
   • Division of labor between HSPA4 and HSPA4L not resolved
7. 2017 Medium

   Established a post-transcriptional repression mechanism connecting miR-429 dysregulation to reduced HSPA4L in human asthenospermia.

   Evidence Luciferase reporter of HSPA4L 3'UTR, transfection, qRT-PCR, and Western blot in patient sperm samples

   PMID:28598115

   Open questions at the time

   • Causal contribution of miR-429/HSPA4L axis to human infertility not proven
   • Correlative clinical data only
8. 2019 Medium

   Placed HSPA4L downstream of HSF1 as a pro-survival effector under proteasome stress in cancer cells.

   Evidence shRNA knockdown with bortezomib, cleaved caspase-3/PARP Western blots, HSF1 nuclear translocation, and triptolide inhibition in multiple myeloma cells

   PMID:31899217

   Open questions at the time

   • Substrates protecting myeloma cells not identified
   • Single cell-context; generality across tumors untested
9. 2022 High

   Resolved the biochemical mechanism, defining HSPA4L as a holdase/disaggregase and mapping the C-terminal domains responsible for refolding via a PA28α-like activity.

   Evidence In vitro aggregation suppression and luciferase reactivation assays with domain-deletion and PA28α chimera mutants in reticulocyte lysate with Hsc70/Hsp40

   PMID:35237814

   Open questions at the time

   • Physiological substrates in vivo not identified
   • Structural basis of the PA28α-like H-domain function not solved
10. 2024 Medium

    Demonstrated cross-species functional conservation of HSPA4L in supporting male germ cell development.

    Evidence Transgenic rescue of Drosophila Hsc70Cb knockdown testes with human HSPA4L cDNA (preprint)

    PMID:bio_10.1101_2024.12.09.627449

    Open questions at the time

    • Only partial rescue achieved
    • Preprint, single lab; mechanism of germ-cell support not defined

• The endogenous physiological substrates of HSPA4L in germ cells, lung, and tumor cells remain unidentified, leaving the link between its in vitro holdase activity and specific in vivo phenotypes incomplete.
• No in vivo substrate repertoire defined
• No high-resolution structure of the chaperone in complex with substrate
• Mechanism of selective Nogo-A binding unexplained